Markets Overview

  • ASX SPI 200 futures up 0.1% to 7,455.00
  • Dow Average up 0.3% to 36,441.38
  • Aussie up 0.4% to 0.7426 per US$
  • U.S. 10-year yield rose 4.2bps to 1.4950%
  • Australia 3-year bond yield fell 6bps to 0.86%
  • Australia 10-year bond yield fell 6bps to 1.75%
  • Gold spot up 0.4% to $1,825.95
  • Brent futures up 1.1% to $83.67/bbl

Economic Events

  • 7:30am: (AU) Oct. NAB Business Confidence, prior 13
  • 7:30am: (AU) Oct. NAB Business Conditions, prior 5
  • 9:30am: (AU) Nov. ANZ Roy Morgan Weekly Consumer, prior 108.4
  • 11am: (AU) Australia to Sell A$150 Million 0.75% 2027 Bonds

U.S. stocks edged higher, with the S&P 500 notching its longest winning streak since 2017, after corporate earnings, strong hiring data and a Covid treatment breakthrough bolstered optimism in the world’s largest economy. The dollar and Treasuries fell.

Other News

Big Bird, like scores of American 6-year-olds, became eligible for the Pfizer-BioNTech coronavirus vaccine last week. On Saturday, he announced he had lined up for his shot.
“My wing is feeling a little sore, but it’ll give my body an extra protective boost that keeps me and others healthy,” the big, feathered yellow bird, who is eternally 6 years old, wrote on Twitter.
“Good on ya, @BigBird. Getting vaccinated is the best way to keep your whole neighborhood safe,” President Biden tweeted in response.
The announcement ruffled feathers among some conservatives, however.
“Government propaganda … for your 5-year-old!” Sen. Ted Cruz (R-Tex.) tweeted.
Almost a year after their parents and grandparents became eligible, young U.S. children are now signing up for vaccine doses to protect them from the virus that upended their childhoods, in many cases keeping them away from schools, playdates and vacations.
The Centers for Disease Control and Prevention signed off last week on smaller doses of the Pfizer-BioNTech coronavirus vaccine for children ages 5 to 11. One Texas children’s hospital averaged 1,000 appointments an hour when it opened sign-ups after the FDA green light, The Washington Post reported.